Last update: 03/08/2010

Topics

Search by | Clinical Trial Tools

About Trials | Expanded Access | Other Trial Resources | PDQ Services | Travel for Treatment

Search by

treatment type Includes links to related PubMed abstracts

lymphoma subtype Includes filters for newly diagnosed or recurrent disease All studies for Lymphomas

Other Ways   New Trials Includes filters for age, alternative Med, fatigue, first-line, grade, phase, stage, and refractory disease

by State or Country Locate lymphoma studies in your state or country

and by ...

Clinical Trial Search Tools A) Geographic State | World  (CLL | Lymphoma specific)   B) New studies since  Mar | Feb | Oct    C) Phase III for Indolent / Aggressive  comparing and advancing the standard of care   D) Gene profiling- / marker-based for  Follicular | CLL | DLBCL | Hodgkins | MCL | T-cell | Unspecified   E) Help bringing trials to You by Pharmatech   F) Search using TrialCheck.org       (easy to use - by Coalition of Cancer Cooperative Groups) G) Let us Help You Find Trials email a PAL H) Trials of interest based on clinical circumstances First Therapy - Low Toxic  | First Primary Therapy   Relapsed / Refractory Lymphoma | Other | I) Pipeline of new agents with links to trials J) NCI-sponsored trials for Lymphoma  Cancer.gov  K) International Clinical Trial Search by WHO

  PAL is dependent of public-only support for funding.  Please lend a hand.

Donate Your Used Vehicle or Make an Email-Pledge or Donate by Mail or

Donate online with a credit card.  It's easy, safe and secure: 

Patients Against Lymphoma is a 501(3)(c) non profit organization  
Your donation is tax deductible

 

Related Resources

	Education: NCI Taking Part in Cancer Treatment Research Studies  Cancer.gov | PDF
	Oncologists Divided Over Experimental Treatments  Medscape (free login req.)  The majority of respondents — 61% — said that patients should be discouraged from using  off-protocol treatments. A smaller number — 31% — said they should not be available at all.  More than half the oncologists surveyed said that patients considering trial enrollment should be informed if an investigational therapy is available; 34% disagreed. A total of 26% of respondents thought that patients considering enrollment have a right to off-protocol  treatment; 56% said this is not the case.
	Survey Reveals Blood Cancer Patients Not Being Directed to Clinical Trials Despite  Their Importance in Developing New Therapies  prnewswire   Kornhaber said the findings were troubling because clinical trials are such a crucial step in the development of new treatments and are often the only remaining hope for patients.  "For many cancer patients, clinical trials present an opportunity to take advantage of  promising new treatments not yet available and may offer new hope for patients when  the standard treatments are not effective," Kornhaber said.  She added that most types of leukemia, lymphoma and myeloma are not curable, yet  many promising therapies are being tested in clinical trials to assess if they will delay  the progression of disease and/or reduce side effects compared to standard therapies. "
	Results of a survey to help understand why cancer patients choose to enter or not to  enter cancer clinical trials.  actmagazine
	Public Registration of Clinical Trials ~ Robert Steinbrook, M.D.  NEJM 2004
	Would a clinical trial be appropriate for me? Questions for your doctor.  A free printable brochure prepared by Patients Against Lymphoma  PDF
	How to Use and Conduct More Specific ClinicalTrials.gov Searches
	Protocol registration system (for drug sponsors)  http://prsinfo.clinicaltrials.gov
	Draft - select trial query by menu  PAL